News Author: HT Staff Publish date: October 18, 2018
The U.S.
News Author: HT Staff Publish date: October 14, 2018
The U.S.
News Author: HT Staff Publish date: October 13, 2018
The U.S.
News Author: HT Staff Publish date: October 11, 2018
The U.S.
News Author: HT Staff Publish date: October 10, 2018
Update: On October 12, 2018, Affimed N.V. received a notification from the U.S. Food and Drug Administration (FDA) saying the agency concurred...
News Author: HT Staff Publish date: October 9, 2018
The U.S.
News Author: HT Staff Publish date: October 8, 2018
Danish researchers conducted a large, 16-year study of patients with venous thromboembolism (VTE) and found a high recurrence risk in all types of VTE...
News Author: HT Staff Publish date: October 5, 2018
Final analysis of the phase 3 DUO trial has shown monotherapy with oral duvelisib results in a statistically significant improvement in progression...
News Author: HT Staff Publish date: October 5, 2018
The U.S.
News Author: HT Staff Publish date: October 3, 2018
Researchers have developed a new risk model for primary myelodysplastic syndromes (MDS) that integrates genetic and clinical information.
The resea...
News Author: HT Staff Publish date: October 3, 2018
The U.S.
News Author: HT Staff Publish date: October 2, 2018
Investigators report that a single leukemic cell unintentionally engineered into the chimeric antigen receptor (CAR) T-cell product can mask it from r...
News Author: HT Staff Publish date: October 1, 2018
Two immunologists have been awarded the Nobel Prize in Physiology or Medicine for discoveries that represent a “paradigmatic shift in the fight aga...
News Author: HT Staff Publish date: September 29, 2018
The U.S.
News Author: HT Staff Publish date: September 28, 2018
A randomized, controlled study of 25 patients has demonstrated that an autologous fecal microbiota transplant (auto-FMT) can restore beneficial gut ba...
